文献速递胸部肿瘤

经气腔播散(STAS)在不典型类癌、大细胞神经内分泌癌和小细胞肺癌中具有预后意义

Spread Through Air Spaces (STAS) Is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung.
PubMed 文献 · J Thorac Oncol · 2019-05-20

研究评估了1992至2012年切除的I至III期肺神经内分泌肿瘤487例中经气腔播散(STAS)的预后价值,采用竞争风险模型分析累积复发率和肺癌特异性累积死亡率。STAS见于26%的肿瘤,与远处转移及更高的累积复发率和肺癌特异性累积死亡率相关,在多变量分析中独立于组织学亚型。

要点

  • STAS见于26%的肺神经内分泌肿瘤,包括16%典型类癌、37%不典型类癌、43%大细胞神经内分泌癌和46%小细胞肺癌。
  • 多变量分析显示STAS与更高的累积复发率(亚风险比=2.85,95%CI 1.73-4.68,p<0.001)和肺癌特异性累积死亡率(亚风险比=2.72,95%CI 1.57-4.70,p<0.001)相关。
  • 在大细胞神经内分泌癌队列中STAS独立与累积复发率和肺癌特异性累积死亡率相关,在小细胞肺癌队列中独立与肺癌特异性累积死亡率相关。

核心结论

  • 在肺神经内分泌肿瘤患者中,STAS与早期远处转移和更差的肺癌特异性累积死亡率相关。
  • 在大细胞神经内分泌癌或小细胞肺癌患者中,STAS是独立的预后不良因素。

研究设计与样本

  • 回顾性评估1992至2012年间切除的病理I至III期肺神经内分泌肿瘤患者487例的肿瘤切片中STAS存在情况。
  • 队列包括典型类癌299例、不典型类癌38例、大细胞神经内分泌癌93例和小细胞肺癌57例。
  • 采用竞争风险方法分析累积复发率和肺癌特异性累积死亡率。

主要发现

  • STAS在26%的神经内分泌肿瘤中检出(典型类癌16%、不典型类癌37%、大细胞神经内分泌癌43%、小细胞肺癌46%)。
  • STAS与远处转移相关,并在总体队列及不典型类癌、大细胞神经内分泌癌和小细胞肺癌队列中与更高的累积复发率和肺癌特异性累积死亡率相关。
  • 由于复发和死亡数量少(<5),典型类癌队列未进行预后分析。
  • 按分期分层的多变量分析中,STAS与更高的累积复发率(亚风险比=2.85,95%CI 1.73-4.68,p<0.001)和肺癌特异性累积死亡率(亚风险比=2.72,95%CI 1.57-4.70,p<0.001)显著相关,独立于组织学亚型。
  • 在大细胞神经内分泌癌队列中STAS独立与累积复发率和肺癌特异性累积死亡率相关,在小细胞肺癌队列中STAS独立与肺癌特异性累积死亡率相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Tumor spread through air spaces (STAS) has prognostic significance in lung adenocarcinoma and squamous cell carcinoma. We sought to investigate the prognostic importance of STAS in lung neuroendocrine tumors (NETs). METHODS: All tumor slides from patients with resected pathologic stage I to III lung NETs (N = 487) (299 with typical carcinoid [TC], 38 with atypical carcinoid [AC], 93 with large cell neuroendocrine carcinoma [LCNEC], and 57 with SCLC) treated between 1992 and 2012 were evaluated for presence of STAS. Cumulative incidence of recurrence (CIR) and lung cancer-specific cumulative incidence of death (LC-CID) were analyzed by using a competing-risks approach. RESULTS: STAS was identified in 26% of NETs (16% of TCs, 37% of ACs, 43% of LCNECs, and 46% of SCLCs). STAS was associated with distant metastasis, as well as with higher CIR and LC-CID in the overall cohort and in the AC, LCNEC, and SCLC cohorts (owing to a small number of recurrences and deaths [<5], prognostic analysis was not performed in the TC cohort). In multivariable analysis stratified by stage, STAS was significantly associated with higher CIR (subhazard ratio = 2.85, 95% confidence interval: 1.73-4.68, p < 0.001) and LC-CID (subhazard ratio = 2.72, 95% confidence interval: 1.57-4.70, p < 0.001), independent of histologic subtype. STAS was independently associated with CIR and LC-CID in the LCNEC cohort and LC-CID in the SCLC cohort. CONCLUSIONS: In patients with lung NETs, STAS is associated with early distant metastasis and worse LC-CID. In patients with LCNEC or SCLC, STAS is an independent poor prognostic factor.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Aly RG, Rekhtman N, Li X, et al. Spread Through Air Spaces (STAS) Is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung. J Thorac Oncol. 2019. PMID: 31121325. doi:10.1016/j.jtho.2019.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。